Print

Medgenics, Inc. Announces EPODURE to be Presented in Poster Session at the American Society of Nephrology’s Kidney Week 2012  
10/23/2012 9:20:01 AM

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG) (the “Company”), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced the Company will be presenting a poster at the upcoming American Society of Nephrology’s Kidney Week 2012, taking place from October 30 to November 4 in San Diego.
//-->